Patents for C07K 19 - Hybrid peptides (29,428) |
---|
05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
05/17/2011 | US7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies |
05/17/2011 | US7943144 Herpes simplex virus complex |
05/17/2011 | CA2228221C Papillomavirus polyprotein constructs |
05/12/2011 | WO2011056911A2 Compositions and methods for enhancing production of a biological product |
05/12/2011 | WO2011056899A2 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps |
05/12/2011 | WO2011056721A2 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
05/12/2011 | WO2011055897A9 Fusion protein binding specifically to constant region of antibody, preparation thereof and method for isolating antibody using the same |
05/12/2011 | WO2011055897A2 Fusion protein binding specifically to constant region of antibody, preparation thereof and method for isolating antibody using the same |
05/12/2011 | WO2011011347A3 Functionalization of silk material by avidin-biotin interaction |
05/12/2011 | WO2010065969A8 Sparc binding scfcs |
05/12/2011 | US20110112990 Efficient Production of Peptides |
05/12/2011 | US20110112279 Compositions and Methods Relating to STOP-1 |
05/12/2011 | US20110112276 Mutated immunoglobulin-binding protein |
05/12/2011 | US20110111494 Multimeric tnf receptors |
05/12/2011 | US20110110970 Chimeric vaccines |
05/12/2011 | US20110110964 Immunogenic peptides and their use in transplantation |
05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
05/12/2011 | US20110110901 Methods of long-term culture of eukaryotic cells and uses thereof |
05/12/2011 | US20110110852 Multivalent Antibodies and Uses Therefor |
05/12/2011 | CA2816401A1 Generation of antigenic virus-like particles through protein-protein linkages |
05/12/2011 | CA2776563A1 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
05/11/2011 | EP2319935A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
05/11/2011 | EP2319934A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
05/11/2011 | EP2319929A1 IL-1 related polypeptides |
05/11/2011 | EP2319928A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
05/11/2011 | EP2318435A2 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc |
05/11/2011 | EP2318431A2 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
05/11/2011 | CN101139556B Highly effective production method for recombinant alpha-glucanase fusion protein and related expression carrier and bacterial strain |
05/10/2011 | US7939650 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
05/10/2011 | US7939641 Comprises fusion proteins for diagnosis and treatment of creutzfeldt- jakob, nervous system, atherosclerosis, diabetes, amyloidosis and viral infections |
05/10/2011 | US7939631 APO-2 receptor polypeptides |
05/10/2011 | US7939318 Flexible vaccine assembly and vaccine delivery platform |
05/10/2011 | US7939268 Compositions and methods for the diagnosis and treatment of tumor |
05/10/2011 | CA2363712C Long lasting insulinotropic peptides |
05/10/2011 | CA2296813C Novel synthetic genes for plant gums |
05/05/2011 | WO2011053991A2 Vault complexes for cytokine delivery |
05/05/2011 | WO2011053065A2 Catechol polyethylene glycol derivative and protein or peptide conjugates, and method for preparing same |
05/05/2011 | WO2011052679A1 Peptide capable of promoting cell proliferation, and use thereof |
05/05/2011 | WO2010129853A3 TRANSDUCIBLE DELIVERY OF NUCLEIC ACIDS USING MODIFIED dsRNA BINDING DOMAINS |
05/05/2011 | WO2010111597A3 Immunodominant compositions and methods of use therefor |
05/05/2011 | US20110105403 Peptides |
05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
05/05/2011 | US20110104675 Methods and Compositions for Diagnosing Carcinomas |
05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
05/05/2011 | US20110104194 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
05/05/2011 | US20110104163 Anti-hiv domain antibodies and method of making and using same |
05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
05/05/2011 | US20110104058 Dimeric molecular complexes |
05/05/2011 | CA2779512A1 Vault complexes for cytokine delivery |
05/05/2011 | CA2778893A1 Dna vaccine against the yellow fever virus |
05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
05/04/2011 | EP2316950A1 Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same |
05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
05/04/2011 | EP2316486A2 Cripto blocking antibodies and uses thereof |
05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
05/04/2011 | CN102046661A Polypeptide-polymer conjugates and methods of use thereof |
05/04/2011 | CN102046657A Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
05/04/2011 | CN102046207A Drug fusions and conjugates |
05/04/2011 | CN102041263A Chicken alpha interferon/interleukin 2 chimeric gene |
05/04/2011 | CN102040653A Tag peptide capable of realizing affinity binding with polystyrene and method for preparing enzyme-linked immuno solid phase antigen with same |
05/04/2011 | CN102038957A Efficient cell nucleus targeted medicine vector and application thereof to preparing antineoplastic medicines |
05/04/2011 | CN101413009B Preparation of human amylin mutant-pramlintide with modified structure |
05/04/2011 | CN101148475B Human breast cancer resisting recombination immunotoxin M4G3/ScFv-PE40 |
05/03/2011 | USRE42324 Compound for treatment of allergy and asthma |
05/03/2011 | CA2469815C Methods for purifying protein |
05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
05/03/2011 | CA2206509C Novel hedgehog-derived polypeptides |
04/28/2011 | WO2011050052A2 Protein agent for diabetes treatment and beta cell imaging |
04/28/2011 | WO2011047631A1 Proteins or polypeptides with cd137l function and genes encoding the same and uses thereof |
04/28/2011 | WO2011005523A3 Galectin-immunoglobulin chimeric molecules |
04/28/2011 | US20110098444 Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis |
04/28/2011 | US20110098441 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
04/28/2011 | US20110098211 Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same |
04/28/2011 | US20110098197 Method for Specific Covalent Coupling of Antibody Using a Photoactivable Protein G Variant |
04/28/2011 | US20110097355 Virus-like particles as vaccines for paramyxovirus |
04/28/2011 | US20110097354 System for the expression of peptides on the bacterial surface |
04/28/2011 | CA2777753A1 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis |
04/28/2011 | CA2774032A1 Anti-gcc antibody molecules and related compositions and methods |
04/27/2011 | EP2314694A2 BAFF receptor (BCMA), an immunoregulatory agent |
04/27/2011 | EP2314684A1 Fluorescent protein and chromoprotein |
04/27/2011 | EP2314683A1 Fluorescent protein and chromoprotein |
04/27/2011 | EP2314682A2 Fluorescent protein |
04/27/2011 | EP2314676A1 Compositions and methods for the treatment of immune related diseases |
04/27/2011 | EP2314630A1 Method of producing immunogenic lipopeptides comprising T-helper and Cytotoxic T Lymphocyte (CTL) epitopes |
04/27/2011 | EP1732947B1 Growth factor binding constructs materials and methods |
04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
04/27/2011 | EP1524994B1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
04/27/2011 | EP1272633B1 Compositions and methods for dendritic cell-based immunotherapy |
04/27/2011 | CN102031266A Insect-resistant fusion gene, fused protein and application of fused protein |
04/27/2011 | CN102030829A Anti-melanoma cytotoxic lymphocyte (CTL) multi-epitope peptide and application thereof |
04/27/2011 | CN102030828A CTLA4-Ig fusion protein mutants with high affinity |
04/27/2011 | CN102028941A Neisseria meningitidis group B recombinant protein chimeric vaccine and preparation method thereof |
04/27/2011 | CN101555483B Echinococcus granulosus EgFABP-Eg95 polypeptide and preparation and application of recombinant brevibacterium vaccine thereof |
04/27/2011 | CN101514231B Fusion protein for resisting formation of thrombus targetedly and preparation method and application thereof |
04/27/2011 | CN101260157B Fusion polypeptide and application thereof in preparing antineoplastic, antiviral and intracellular bacterial parasite infection curing medicament |
04/27/2011 | CN101172091B Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same |
04/26/2011 | US7932358 Antibodies to JTT-1 protein and cells secreting such antibodies |
04/26/2011 | US7932357 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |